Idexx Laboratories Stock Z Score

IDXX Stock

USD 428.59 11.35 2.72%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out IDEXX Laboratories Piotroski F Score and IDEXX Laboratories Valuation analysis.

For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.

At this time, IDEXX Laboratories' Additional Paid In Capital is fairly stable compared to the past year. Net Working Capital is likely to rise to about 570.9 M in 2024, whereas Capital Surpluse is likely to drop slightly above 1.1 B in 2024. At this time, IDEXX Laboratories' Income Before Tax is fairly stable compared to the past year. Net Income is likely to rise to about 887.3 M in 2024, despite the fact that Total Other Income Expense Net is likely to grow to (34.2 M).

IDEXX Laboratories Company Z Score Analysis

IDEXX Laboratories' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

Sum Of

5 Factors

More About Z Score | All Equity Analysis

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

IDEXX Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for IDEXX Laboratories is extremely important. It helps to project a fair market value of IDEXX Stock properly, considering its historical fundamentals such as Z Score. Since IDEXX Laboratories' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of IDEXX Laboratories' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of IDEXX Laboratories' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Short Term Debt	Common Stock	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Good Will	Long Term Debt	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.73	0.49	0.91	0.95	0.98	0.82	0.96	0.72	0.14	0.54	-0.89	0.98	0.6	0.8	0.62	0.05	0.72	0.85	-0.53	-0.46	0.79	0.71	0.7	0.69
Total Stockholder Equity	0.73		-0.22	0.89	0.59	0.74	0.2	0.69	0.61	-0.37	0.14	-0.56	0.68	0.09	0.5	0.0	0.52	0.14	0.47	-0.72	-0.44	0.77	0.79	0.8	0.73
Net Debt	0.49	-0.22		0.17	0.61	0.47	0.89	0.48	0.26	0.73	0.51	-0.5	0.53	0.64	0.49	0.82	-0.61	0.8	0.6	0.15	0.04	0.24	0.01	-0.08	0.09
Retained Earnings	0.91	0.89	0.17		0.84	0.92	0.55	0.83	0.76	-0.08	0.33	-0.84	0.88	0.42	0.74	0.33	0.33	0.45	0.73	-0.72	-0.44	0.87	0.76	0.71	0.74
Accounts Payable	0.95	0.59	0.61	0.84		0.96	0.86	0.87	0.74	0.18	0.53	-0.91	0.96	0.69	0.86	0.71	0.06	0.79	0.89	-0.55	-0.47	0.7	0.61	0.56	0.6
Net Receivables	0.98	0.74	0.47	0.92	0.96		0.79	0.91	0.72	0.07	0.46	-0.89	0.98	0.61	0.83	0.62	0.15	0.72	0.88	-0.65	-0.49	0.81	0.71	0.69	0.69
Total Liab	0.82	0.2	0.89	0.55	0.86	0.79		0.8	0.51	0.51	0.65	-0.8	0.84	0.78	0.72	0.89	-0.37	0.92	0.82	-0.16	-0.29	0.48	0.35	0.33	0.38
Total Current Assets	0.96	0.69	0.48	0.83	0.87	0.91	0.8		0.64	0.25	0.56	-0.78	0.91	0.48	0.69	0.57	-0.08	0.67	0.76	-0.34	-0.34	0.75	0.7	0.72	0.68
Intangible Assets	0.72	0.61	0.26	0.76	0.74	0.72	0.51	0.64		0.17	0.63	-0.8	0.67	0.39	0.84	0.32	0.34	0.37	0.61	-0.41	-0.24	0.57	0.51	0.3	0.35
Short Term Debt	0.14	-0.37	0.73	-0.08	0.18	0.07	0.51	0.25	0.17		0.48	-0.15	0.1	0.19	0.21	0.33	-0.75	0.3	0.18	0.56	0.61	0.11	-0.19	-0.42	-0.19
Common Stock	0.54	0.14	0.51	0.33	0.53	0.46	0.65	0.56	0.63	0.48		-0.64	0.52	0.61	0.66	0.56	-0.24	0.55	0.52	0.1	-0.19	0.1	0.16	0.08	-0.03
Treasury Stock	-0.89	-0.56	-0.5	-0.84	-0.91	-0.89	-0.8	-0.78	-0.8	-0.15	-0.64		-0.9	-0.79	-0.9	-0.69	-0.15	-0.73	-0.86	0.54	0.52	-0.59	-0.53	-0.47	-0.45
Property Plant Equipment	0.98	0.68	0.53	0.88	0.96	0.98	0.84	0.91	0.67	0.1	0.52	-0.9		0.69	0.81	0.68	0.03	0.77	0.89	-0.58	-0.53	0.76	0.66	0.66	0.67
Current Deferred Revenue	0.6	0.09	0.64	0.42	0.69	0.61	0.78	0.48	0.39	0.19	0.61	-0.79	0.69		0.74	0.89	-0.15	0.88	0.82	-0.32	-0.59	0.2	0.28	0.24	0.04
Good Will	0.8	0.5	0.49	0.74	0.86	0.83	0.72	0.69	0.84	0.21	0.66	-0.9	0.81	0.74		0.67	0.2	0.72	0.91	-0.51	-0.41	0.56	0.62	0.36	0.21
Long Term Debt	0.62	0.0	0.82	0.33	0.71	0.62	0.89	0.57	0.32	0.33	0.56	-0.69	0.68	0.89	0.67		-0.28	0.98	0.81	-0.16	-0.49	0.2	0.29	0.28	0.09
Net Tangible Assets	0.05	0.52	-0.61	0.33	0.06	0.15	-0.37	-0.08	0.34	-0.75	-0.24	-0.15	0.03	-0.15	0.2	-0.28		-0.26	0.01	-0.66	-0.43	0.11	0.33	0.32	0.16
Long Term Debt Total	0.72	0.14	0.8	0.45	0.79	0.72	0.92	0.67	0.37	0.3	0.55	-0.73	0.77	0.88	0.72	0.98	-0.26		0.88	-0.23	-0.52	0.33	0.43	0.4	0.2
Capital Surpluse	0.85	0.47	0.6	0.73	0.89	0.88	0.82	0.76	0.61	0.18	0.52	-0.86	0.89	0.82	0.91	0.81	0.01	0.88		-0.53	-0.5	0.62	0.69	0.51	0.3
Deferred Long Term Liab	-0.53	-0.72	0.15	-0.72	-0.55	-0.65	-0.16	-0.34	-0.41	0.56	0.1	0.54	-0.58	-0.32	-0.51	-0.16	-0.66	-0.23	-0.53		0.6	-0.6	-0.55	-0.56	-0.51
Short Long Term Debt	-0.46	-0.44	0.04	-0.44	-0.47	-0.49	-0.29	-0.34	-0.24	0.61	-0.19	0.52	-0.53	-0.59	-0.41	-0.49	-0.43	-0.52	-0.5	0.6		-0.08	-0.46	-0.68	-0.3
Long Term Investments	0.79	0.77	0.24	0.87	0.7	0.81	0.48	0.75	0.57	0.11	0.1	-0.59	0.76	0.2	0.56	0.2	0.11	0.33	0.62	-0.6	-0.08		0.67	0.55	0.73
Net Invested Capital	0.71	0.79	0.01	0.76	0.61	0.71	0.35	0.7	0.51	-0.19	0.16	-0.53	0.66	0.28	0.62	0.29	0.33	0.43	0.69	-0.55	-0.46	0.67		0.82	0.42
Net Working Capital	0.7	0.8	-0.08	0.71	0.56	0.69	0.33	0.72	0.3	-0.42	0.08	-0.47	0.66	0.24	0.36	0.28	0.32	0.4	0.51	-0.56	-0.68	0.55	0.82		0.69
Capital Stock	0.69	0.73	0.09	0.74	0.6	0.69	0.38	0.68	0.35	-0.19	-0.03	-0.45	0.67	0.04	0.21	0.09	0.16	0.2	0.3	-0.51	-0.3	0.73	0.42	0.69

Click cells to compare fundamentals

To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.

Competition

Predict IDEXX Laboratories

According to the company's disclosures, IDEXX Laboratories has a Z Score of 0.0. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.

IDEXX Laboratories ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, IDEXX Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to IDEXX Laboratories' managers, analysts, and investors.

Environmental

Governance

Social

IDEXX Laboratories Institutional Holders

Institutional Holdings refers to the ownership stake in IDEXX Laboratories that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of IDEXX Laboratories' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing IDEXX Laboratories' value.

		Shares
Blair William & Co	2024-06-30	1.2 M
Brown Advisory Holdings Inc	2024-09-30	1.1 M
Norges Bank	2024-06-30	994.4 K
Fundsmith Investment Services Ltd.	2024-09-30	865 K
Goldman Sachs Group Inc	2024-06-30	815.4 K
Legal & General Group Plc	2024-06-30	777.3 K
Northern Trust Corp	2024-09-30	769.5 K
Jpmorgan Chase & Co	2024-06-30	756.2 K
Ubs Asset Mgmt Americas Inc	2024-09-30	751.9 K
Vanguard Group Inc	2024-09-30	9.7 M
Blackrock Inc	2024-06-30	9.6 M

IDEXX Fundamentals

	Return On Equity	0.59
	Return On Asset	0.23
	Profit Margin	0.23 %
	Operating Margin	0.37 %
	Current Valuation	34.86 B
	Shares Outstanding	81.88 M
	Shares Owned By Insiders	0.94 %
	Shares Owned By Institutions	94.24 %
	Number Of Shares Shorted	2.08 M
	Price To Earning	61.31 X
	Price To Book	21.12 X
	Price To Sales	8.89 X
	Revenue	3.66 B
	Gross Profit	2 B
	EBITDA	1.1 B
	Net Income	845.04 M
	Cash And Equivalents	114.36 M
	Cash Per Share	1.37 X
	Total Debt	1.07 B
	Debt To Equity	3.27 %
	Current Ratio	0.89 X
	Book Value Per Share	19.72 X
	Cash Flow From Operations	906.51 M
	Short Ratio	3.32 X
	Earnings Per Share	10.35 X
	Price To Earnings To Growth	4.39 X
	Target Price	476.76
	Number Of Employees	11 K
	Beta	1.36
	Market Capitalization	34.17 B
	Total Asset	3.26 B
	Retained Earnings	4.44 B
	Working Capital	543.71 M
	Current Asset	821.63 M
	Current Liabilities	856.76 M
	Net Asset	3.26 B

About IDEXX Laboratories Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze IDEXX Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IDEXX Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IDEXX Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for IDEXX Stock Analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Idexx Laboratories Stock Z Score

IDEXX Laboratories Company Z Score Analysis

Z Score

Sum Of

5 Factors

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

IDEXX Z Score Driver Correlations

IDEXX Laboratories ESG Sustainability

IDEXX Laboratories Institutional Holders

IDEXX Fundamentals

About IDEXX Laboratories Fundamental Analysis

Also Currently Popular

Additional Tools for IDEXX Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY